|
|
|
The gene p53 is the focus of considerable clinical interest as it is frequently mutated in human cancers. The protein it encodes, p53, is an important part of the cell-suicide system that keeps DNA damage in check.
This week researchers report in Nature (Vol. 416, No. 6880, 04 Apr 02) that p53-mediated hara-kiri also seems to depend upon two other proteins, called p63 and p73. If both these are absent p53 seems unable to nip DNA damage in the bud. "These data may portend a greater role for these proteins in tumour suppression and chemosensitivity," conclude Tyler Jacks of the Massachusetts Institute of Technology, Cambridge, Massachusetts, and the Howard Hughes Medical Institute, Chevy Chase, Maryland, and colleagues. CONTACT: Tyler Jacks
tel +1 617 253 0262,
e-mail tjacks@mit.edu (C) Nature press release.
Message posted by: Trevor M. D'Souza
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|